![Deborah Ascheim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Deborah Ascheim
Director/Board Member at
LONGEVERON INC.
Net worth: 2 524 $ as of 2026-07-30
Profile
Deborah D.
Ascheim is currently Director at Longeveron, Inc. since 2026 and Chief Medical Officer-Fractional at Rejuvenate Bio, Inc. Former roles include Vice Chairman at Physicians for Human Rights and Chief Medical Officer at Capricor Therapeutics, Inc. from 2015 to 2018.
Education includes undergraduate studies at Wellesley College and a doctorate from New York University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-18 | 3,600 ( 0.01% ) | 2 524 $ | 2026-07-30 |
Deborah Ascheim active positions
| Companies | Position | Start |
|---|---|---|
| LONGEVERON INC. | Director/Board Member | 2026-06-30 |
Rejuvenate Bio, Inc.
 Rejuvenate Bio, Inc. BiotechnologyHealth Technology Develops novel gene therapies for dogs | Corporate Officer/Principal | - |
Former positions of Deborah Ascheim
| Companies | Position | End |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-10-31 |
Physicians for Human Rights
 Physicians for Human Rights Miscellaneous Commercial ServicesCommercial Services Protects human health by protecting human rights | Director/Board Member | - |
Training of Deborah Ascheim
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
21
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Wellesley College
 Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Physicians for Human Rights
Physicians for Human Rights Miscellaneous Commercial ServicesCommercial Services Protects human health by protecting human rights | Commercial Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longeveron, Inc.
 Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
Rejuvenate Bio, Inc.
Rejuvenate Bio, Inc. BiotechnologyHealth Technology Develops novel gene therapies for dogs | Health Technology |
- Stock Market
- Insiders
- Deborah Ascheim
